This topic contains a solution. Click here to go to the answer

Author Question: Imagine a hypothetical study using a nonequivalent comparison group designed to assess the ... (Read 160 times)

crobinson2013

  • Hero Member
  • *****
  • Posts: 535
Imagine a hypothetical study using a nonequivalent comparison group designed to assess the effectiveness of an anti-drug, Just Say No, campaign. In this study students at school X receive a semester-long series of Just Say No lectures.
 
  Students at school Y across town do not receive the intervention. Unfortunately, during the semester a student at school Y died after an accidental drug overdose. This incident may have influenced drug use at school Y (but not school X) and consequently make it impossible to interpret our research findings. Which of the following threats to internal validity is present in this study?
   
 a. selection-instrumentation
   b. selection-maturation
   c. selection-history
   d. selection-testing

Question 2

In the context of experimental design, double blind refers to the situation in which
 
  a. neither the experimenter nor the participant knows which experimental treatment the participant is receiving. b. the experimenter randomly chooses which group and treatment sequence each participant is assigned to.
  c. neither the data analyst nor the participant knows what hypothesis is being tested.
  d. two investigators analyze the data independently, and both are kept unaware of the identity of all participants.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ebenov

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

C

Answer to Question 2

A




crobinson2013

  • Member
  • Posts: 535
Reply 2 on: Jul 13, 2018
Thanks for the timely response, appreciate it


T4T

  • Member
  • Posts: 348
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library